Healthcare
Acted for Caring Homes Group Limited on its £600 million refinancing with the Bank of Scotland
Acted for Caring Homes Group Limited on its joint venture with Inner Circle for the development of care homes
Acted for St Martins Healthcare Limited, a wholly-owned subsidiary of NYSE listed healthcare group HCA Holdings, Inc, on its recommended cash offer for PLUS-quoted UK based primary care medical services provider, General Medical Clinics plc
Acted for Circle Group on the extension and restructuring of senior and mezzanine facilities, and related equity JV arrangements, in respect of Circle Hospital Bath
Acted for Vector Properties Limited acting as asset managers on behalf of 57 Danish private investment vehicles in relation to the transfer of 57 residential care homes formerly operated by the Southern Cross Group of Companies to new operators including Four Seasons, Care UK and Countrywide
Acted for Cygnet 2008 Limited on its acquisition of the entire issued share capital of Cygnet 2002 Limited for £340 million. We also acted for Cygnet Health Care Limited on its acquisition of Springs Community Limited
Acted for Circle in respect of the financing of its Reading hospital by Ropemaker Properties Limited and various group reorganisations
Acted for Audley Court Limited on a £21 million ‘assisted living’ joint venture with Raven Group, and the acquisition of two domiciliary care businesses
Acted for the management team of Raven Audley Court PLC advising the team on the disposal of Audley to a subsidiary of the Moorfield Group, MREF Holdings SARL
Acted for Parexel International Corporation on its commercial contracts with leading pharmaceutical companies, and corporate and litigation matters including in relation to an adverse reaction by six volunteers during a health trial
Acted for Queen Mary, University of London on a range of commercialisation projects, including:
- the development of technology relating to the detection of biomarkers based on micro-ribonucleic acid (microRNA) for the detection of various cancers and women’s health indications
- the use of annexin and related amino acid sequences for the management of inflammatory pathologies and arthritides
- the development of therapeutic monoclonal antibodies for oncology and cardiovascular indications
Acted for Re-Cognition Health, the specialist centre for the assessment, management and treatment of cognitive impairment on its start-up and initial inward investment
Acted for various healthcare providers in connection with real estate, redevelopment and planning issues, including Circle Partnership in connection with its new hospital, CircleReading